title: Prefrontal and monoaminergic contributions to stop-signal task performance in rats.
abstract: Defining the neural and neurochemical substrates of response inhibition is of crucial importance for the study and treatment of pathologies characterized by impulsivity such as attention-deficit/hyperactivity disorder and addiction. The stop-signal task (SST) is one of the most popular paradigms used to study the speed and efficacy of inhibitory processes in humans and other animals. Here we investigated the effect of temporarily inactivating different prefrontal subregions in the rat by means of muscimol microinfusions on SST performance. We found that dorsomedial prefrontal cortical areas are important for inhibiting an already initiated response. We also investigated the possible neural substrates of the selective noradrenaline reuptake inhibitor atomoxetine via its local microinfusion into different subregions of the rat prefrontal cortex. Our results show that both orbitofrontal and dorsal prelimbic cortices mediate the beneficial effects of atomoxetine on SST performance. To assess the neurochemical specificity of these effects, we infused the α2-adrenergic agonist guanfacine and the D(1)/D(2) antagonist α-flupenthixol in dorsal prelimbic cortex to interfere with noradrenergic and dopaminergic neurotransmission, respectively. Guanfacine, which modulates noradrenergic neurotransmission, selectively impaired stopping, whereas blocking dopaminergic receptors by α-flupenthixol infusion prolonged go reaction time only, confirming the important role of noradrenergic neurotransmission in response inhibition. These results show that, similar to humans, distinct networks play important roles during SST performance in the rat and that they are differentially modulated by noradrenergic and dopaminergic neurotransmission. This study advances our understanding of the neuroanatomical and neurochemical determinants of impulsivity, which are relevant for a range of psychiatric disorders.
authors.affiliation: Department of Experimental Psychology and Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge CB2 3EB, United Kingdom. andbari@gmail.com
authors.forename: Andrea
authors.initials: A
authors.lastname: Bari
authors.forename: Adam C
authors.initials: AC
authors.lastname: Mar
authors.forename: David E
authors.initials: DE
authors.lastname: Theobald
authors.forename: Sophie A
authors.initials: SA
authors.lastname: Elands
authors.forename: Kelechi C N A
authors.initials: KC
authors.lastname: Oganya
authors.forename: Dawn M
authors.initials: DM
authors.lastname: Eagle
authors.forename: Trevor W
authors.initials: TW
authors.lastname: Robbins
mesh_terms: D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism*; D007175:Impulsive Behavior / Q000503:physiopathology*; D008297:Male; D009433:Neural Inhibition; D017397:Prefrontal Cortex / Q000503:physiopathology*; D011597:Psychomotor Performance; D051381:Rats
chemical_list: D015306:Biogenic Monoamines